2021 ANA Symposium Frequently Asked Questions

2021 ANA North America Symposium: PAX6, Aniridia, and Beyond

Frequently Asked Questions

A conference on Eye Development and Disease

What is the 2021 Aniridia North America Symposium: PAX6, Aniridia, and Beyond?

This meeting, like its predecessor, the 2019 John F. Anderson Symposium: PAX6 and Beyond, will provide a forum for the scientific community to present current aniridia research findings and facilitate collaboration on future studies. Sessions will focus on aniridia-related issues including glaucoma, corneal health, and genetics.

When is this symposium?

This meeting will be held November 5 – 7 at the University of Virginia in Charlottesville. 

What is the format of this meeting?

This conference is for scientists by scientists, with presentations and roundtable discussions presented to each other using high-level scientific details and language.  

Who will attend this conference?

An international group of 20-30 researchers have committed to attend this conference. The ANA Board of Directors will also be in attendance.  Additionally, leaders of related advocacy organizations have been invited to represent the aniridia patient community and share important news emanating from the symposium.   

Who is funding the symposium?

This meeting was made possible by generous funding and support from the University of Virginia, Vision for Tomorrow, the University of Georgia, and the International WAGR Syndrome Association.

Leave a Comment

Logo - Outline of an eye, with ANA in the middle and Aniridia North America underneath

Aniridia North America
106 W. Calendar Ave
Suite 122
LaGrange, IL 60525

Aniridia North America is registered as a 501(c)(3) non-profit organization in the United States.

EIN: 86-2917141

Resize text-+=